Position in NERV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,426
+$6,536 QoQ
Shares Held
3,320
+552.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 58 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NERV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. NERV ranks #249 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in NERV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,426 | 3,320 | Shares | Defined | 2026-08-14 | |
| 2021-03-31 | $11,890 | 4,072 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,528 | 4,072 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $12,948 | 4,072 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $18,212 | 5,045 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $28,998 | 4,817 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||